Literature DB >> 22486528

LPHN3 and attention-deficit/hyperactivity disorder: interaction with maternal stress during pregnancy.

Zia Choudhry1, Sarojini M Sengupta, Natalie Grizenko, Marie-Eve Fortier, Geeta A Thakur, Johanne Bellingham, Ridha Joober.   

Abstract

BACKGROUND: Attention-deficit/hyperactivity disorder (ADHD) is a heterogeneous behavioral disorder, complex both in etiology and clinical expression. Both genetic and environmental factors have been implicated, and it has been suggested that gene-environment interactions may play a pivotal role in the disorder. Recently, a significant association was reported between ADHD and LPHN3 (which codes for latrophilin 3), and replicated in independent samples.
METHODS: We have examined the association between tag single nucleotide polymorphisms (SNPs) in LPHN3 within the region previously implicated in ADHD. Family based association tests (FBAT) were conducted (n = 380 families) with the categorical diagnosis of ADHD, behavioral and cognitive phenotypes related to ADHD, and response to treatment (given a fixed dose of methylphenidate, 0.5 mg/day). Stratified FBAT analyses, based on maternal smoking and stress during pregnancy, was conducted.
RESULTS: Whereas limited association was observed in the total sample, highly significant interaction between four LPHN3 tag SNPs (rs6551665, rs1947274, rs6858066, rs2345039) and maternal stress during pregnancy was noted. Analysis conducted in the sub-group of mothers exposed to minimal stress during pregnancy showed significant associations with ADHD, behavioral and cognitive dimensions related to ADHD, as well as treatment response. Although extensive association was observed with the candidate SNPs, the findings are partially inconsistent with previously published results with the opposite alleles over-transmitted in these studies.
CONCLUSIONS: These results provide evidence for the interaction between a genetic and environmental factor independently shown to be associated with ADHD. If confirmed in independent large studies, they may present a step forward in unraveling the complex etiology of ADHD.
© 2012 The Authors. Journal of Child Psychology and Psychiatry © 2012 Association for Child and Adolescent Mental Health.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22486528     DOI: 10.1111/j.1469-7610.2012.02551.x

Source DB:  PubMed          Journal:  J Child Psychol Psychiatry        ISSN: 0021-9630            Impact factor:   8.982


  27 in total

1.  Prenatal Lead Exposure Modifies the Impact of Maternal Self-Esteem on Children's Inattention Behavior.

Authors:  Jian Xu; Howard Hu; Rosalind Wright; Brisa N Sánchez; Lourdes Schnaas; David C Bellinger; Sung Kyun Park; Sandra Martínez; Mauricio Hernández-Avila; Martha Maria Téllez-Rojo; Robert O Wright
Journal:  J Pediatr       Date:  2015-06-03       Impact factor: 4.406

Review 2.  Genetic Influence on Efficacy of Pharmacotherapy for Pediatric Attention-Deficit/Hyperactivity Disorder: Overview and Current Status of Research.

Authors:  Nada A Elsayed; Kaila M Yamamoto; Tanya E Froehlich
Journal:  CNS Drugs       Date:  2020-04       Impact factor: 5.749

Review 3.  Gene-environment interactions in genome-wide association studies: current approaches and new directions.

Authors:  Stacey J Winham; Joanna M Biernacka
Journal:  J Child Psychol Psychiatry       Date:  2013-06-28       Impact factor: 8.982

4.  ADGRL3 rs6551665 as a Common Vulnerability Factor Underlying Attention-Deficit/Hyperactivity Disorder and Autism Spectrum Disorder.

Authors:  Djenifer B Kappel; Jaqueline B Schuch; Diego L Rovaris; Bruna S da Silva; Diana Müller; Vitor Breda; Stefania P Teche; Rudimar S Riesgo; Lavínia Schüler-Faccini; Luís A Rohde; Eugenio H Grevet; Claiton H D Bau
Journal:  Neuromolecular Med       Date:  2019-01-16       Impact factor: 3.843

5.  The role of pre-, peri-, and postnatal risk factors in bipolar disorder and adult ADHD.

Authors:  Franziska Tole; Juliane Kopf; Katrin Schröter; Viola Stella Palladino; Christian P Jacob; Andreas Reif; Sarah Kittel-Schneider
Journal:  J Neural Transm (Vienna)       Date:  2019-02-13       Impact factor: 3.575

6.  An Ultraconserved Brain-Specific Enhancer Within ADGRL3 (LPHN3) Underpins Attention-Deficit/Hyperactivity Disorder Susceptibility.

Authors:  Ariel F Martinez; Yu Abe; Sungkook Hong; Kevin Molyneux; David Yarnell; Heiko Löhr; Wolfgang Driever; Maria T Acosta; Mauricio Arcos-Burgos; Maximilian Muenke
Journal:  Biol Psychiatry       Date:  2016-07-14       Impact factor: 13.382

Review 7.  Attention-deficit/hyperactivity disorder genomics: update for clinicians.

Authors:  Josephine Elia; Jillan Sackett; Terri Turner; Martin Schardt; Shih-Ching Tang; Nicole Kurtz; Maura Dunfey; Nadia A McFarlane; Aita Susi; David Danish; Alice Li; Jenelle Nissley-Tsiopinis; Karin Borgmann-Winter
Journal:  Curr Psychiatry Rep       Date:  2012-10       Impact factor: 5.285

8.  Clinical efficacy of recombinant human latrophilin 3 antibody in the treatment of pediatric asthma.

Authors:  Maohua Liu; Jingxiu Zhang; Chengjun Liu
Journal:  Exp Ther Med       Date:  2017-10-25       Impact factor: 2.447

9.  The adhesion-GPCR BAI1 regulates synaptogenesis by controlling the recruitment of the Par3/Tiam1 polarity complex to synaptic sites.

Authors:  Joseph G Duman; Christopher P Tzeng; Yen-Kuei Tu; Tina Munjal; Brandon Schwechter; Tammy Szu-Yu Ho; Kimberley F Tolias
Journal:  J Neurosci       Date:  2013-04-17       Impact factor: 6.167

10.  CDH13 and LPHN3 Gene Polymorphisms in Attention-Deficit/Hyperactivity Disorder: Their Relation to Clinical Characteristics.

Authors:  Ahmet Özaslan; Esra Güney; Mehmet Ali Ergün; İlyas Okur; Dilek Yapar
Journal:  J Mol Neurosci       Date:  2020-07-20       Impact factor: 3.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.